Alzheimer's Disease News and Research

RSS
Alzheimer's disease (AD) is an irreversible, progressive brain disease that slowly destroys memory and thinking skills and, eventually, the ability to carry out the simplest tasks of daily living. In most people with AD, symptoms first appear after age 60. AD is the most common cause of dementia among older people, but it is not a normal part of aging. Dementia refers to a decline in cognitive function that interferes with daily life and activities. AD starts in a region of the brain that affects recent memory, then gradually spreads to other parts of the brain. Although treatment can slow the progression of AD and help manage its symptoms in some people, currently there is no cure for this devastating disease.
New NIA grant advances tools for dementia caregiving

New NIA grant advances tools for dementia caregiving

Discovery explains why women face higher risk of Alzheimer’s and multiple sclerosis

Discovery explains why women face higher risk of Alzheimer’s and multiple sclerosis

Living environment may influence dementia markers in the brain

Living environment may influence dementia markers in the brain

Nemours neurologist wins major NIH award to study hippocampal dysfunction in brain disorders

Nemours neurologist wins major NIH award to study hippocampal dysfunction in brain disorders

New approach protects the brain from radiation-induced cognitive decline

New approach protects the brain from radiation-induced cognitive decline

Scientists uncover how cellular switches guide memory formation

Scientists uncover how cellular switches guide memory formation

CU Boulder researchers advance miniature laser technology for biomedical imaging

CU Boulder researchers advance miniature laser technology for biomedical imaging

Common hospice medications may carry major unintended risks for people with dementia

Common hospice medications may carry major unintended risks for people with dementia

WHO's new Global status report highlights the growing burden of neurological disorders

WHO's new Global status report highlights the growing burden of neurological disorders

Study offers new models for understanding the causes of chemo brain

Study offers new models for understanding the causes of chemo brain

Global health study warns of rising youth deaths amid declining overall mortality

Global health study warns of rising youth deaths amid declining overall mortality

Obesity-linked fat vesicles accelerate amyloid aggregation in Alzheimer’s disease

Obesity-linked fat vesicles accelerate amyloid aggregation in Alzheimer’s disease

University Of California researchers, patients wary of Trump cuts even as some dollars flow again

University Of California researchers, patients wary of Trump cuts even as some dollars flow again

Nasal spray of gold nanoparticles delivers lithium directly to the brain

Nasal spray of gold nanoparticles delivers lithium directly to the brain

Largest study of African American brain tissue reveals key Alzheimer gene activity

Largest study of African American brain tissue reveals key Alzheimer gene activity

Nanotechnology breakthrough reverses Alzheimer’s disease in mice

Nanotechnology breakthrough reverses Alzheimer’s disease in mice

Investigating cannabidiol's role in combating Alzheimer's-related neuroinflammation

Investigating cannabidiol's role in combating Alzheimer's-related neuroinflammation

Cell messengers signal amyloid plaque buildup in obese individuals

Cell messengers signal amyloid plaque buildup in obese individuals

Study links high neuroinflammation in young people with Down Syndrome to Alzheimer's risk

Study links high neuroinflammation in young people with Down Syndrome to Alzheimer's risk

Scientists discover new protein family regulating motility and DNA uptake

Scientists discover new protein family regulating motility and DNA uptake

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.